Announcement on the Use of Idle Self-owned Funds for Cash Management and Entrusted Wealth Management
Securities Code: 300653
Securities Abbreviation: Zhenghai Biological
Announcement No.: 2026-015
Yantai Zhenghai Biological Technology Co., Ltd. (hereinafter referred to as "the Company") held the tenth meeting of the fourth board of directors on March 29, 2026, and approved the proposal on the use of idle self-owned funds for cash management and entrusted wealth management. This initiative aims to improve the efficiency of fund utilization, increase company revenue, and enhance shareholder returns. In accordance with the "Shenzhen Stock Exchange Growth Enterprise Market Listing Rules," "Shenzhen Stock Exchange Self-regulatory Guidelines No. 2 - Standard Operations for Growth Enterprise Market Listed Companies," and other relevant laws and regulations, as well as the provisions of the Company's Articles of Association, the Company intends to use a total amount not exceeding RMB 700 million of idle self-owned funds for cash management and entrusted wealth management. Within this limit, the funds can be used in a rolling manner, and the usage period is valid for 12 months from the date of approval by the Company's 2025 annual shareholders' meeting. The specific details are as follows: